K
Kokila Shah
Researcher at Albert Einstein College of Medicine
Publications - 4
Citations - 2629
Kokila Shah is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: Dendritic cell & Cytokine. The author has an hindex of 4, co-authored 4 publications receiving 2544 citations.
Papers
More filters
Journal ArticleDOI
The nature of the principal type 1 interferon-producing cells in human blood.
Frederick P. Siegal,Norimitsu Kadowaki,Michael Shodell,Patricia Fitzgerald-Bocarsly,Kokila Shah,Stephen Ho,Svetlana Antonenko,Yong-Jun Liu +7 more
TL;DR: Purified IPCs are here shown to be the CD4(+)CD11c- type 2 dendritic cell precursors (pDC2s), which produce 200 to 1000 times more IFN than other blood cells after microbial challenge and are thus an effector cell type of the immune system, critical for antiviral and antitumor immune responses.
Journal ArticleDOI
Evidence of dysregulation of dendritic cells in primary HIV infection.
Rachel Lubong Sabado,Rachel Lubong Sabado,Meagan O’Brien,Meagan O’Brien,Abhignya Subedi,Abhignya Subedi,Li Qin,Li Qin,Nan Hu,Nan Hu,Elizabeth Taylor,Elizabeth Taylor,Oliver Dibben,Oliver Dibben,Andrea Stacey,Andrea Stacey,Jacques Fellay,Jacques Fellay,Kevin V. Shianna,Kevin V. Shianna,Frederick P. Siegal,Michael Shodell,Kokila Shah,Marie Larsson,Jeffrey D. Lifson,Arthur Nádas,Michael Marmor,Richard Hutt,David M. Margolis,David M. Margolis,Donald Garmon,Donald Garmon,Martin Markowitz,Martin Markowitz,Fred T. Valentine,Persephone Borrow,Persephone Borrow,Nina Bhardwaj,Nina Bhardwaj +38 more
TL;DR: It is found that both myeloid DC and plasmacytoid DC levels decline very early during acute HIV infection, which implicates a possible role for DCs in promoting chronic immune activation.
Journal ArticleDOI
Dendritic cell numbers in the blood of HIV-1 infected patients before and after changes in antiretroviral therapy.
TL;DR: In this article, the authors monitored the two major subsets of blood dendritic cells (DCs) in 12 individuals undergoing a change, primarily initiation, of highly active antiretroviral therapy.
Journal ArticleDOI
Interferon-α Generation in Mice Responding to Challenge with UV-Inactivated Herpes Simplex Virus
Tawfiqul Bhuiya,Michael Shodell,Patricia Fitzgerald-Bocarsly,Donna M. Murasko,Kokila Shah,Domenica Drake,Frederick P. Siegal +6 more
TL;DR: In humans with advanced human immunodeficiency virus (HIV) infection, an interferon-α (IFN-α) response by a specialized blood mononuclear cell to herpes simplex virus (HSV) in vitro is in vitro.